SBH
CELG

Segall Bryant & Hamill’s Celgene Corp CELG Stock Holding History

Segall Bryant & Hamill’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-18,602
Closed -$1.85M – 878
2019
Q3 		$1.85M Sell
18,602
-400
-2% -$38K 0.03% 420
2019
Q2 		$1.75M Buy
19,002
+2,859
+18% +$271K 0.03% 431
2019
Q1 		$1.52M Sell
16,143
-13,956
-46% -$1.22M 0.02% 459
2018
Q4 		$1.93M Sell
30,099
-4,373
-13% -$323K 0.03% 410
2018
Q3 		$3.08M Sell
34,472
-2,763
-7% -$244K 0.05% 365
2018
Q2 		$2.96M Buy
37,235
+8,447
+29% +$701K 0.05% 379
2018
Q1 		$2.57M Sell
28,788
-440
-2% -$42.2K 0.06% 279
2017
Q4 		$3.05M Sell
29,228
-4,087
-12% -$461K 0.07% 265
2017
Q3 		$4.86M Buy
33,315
+17,441
+110% +$2.38M 0.11% 197
2017
Q2 		$2.06M Sell
15,874
-208
-1% -$25.5K 0.05% 304
2017
Q1 		$2M Buy
16,082
+243
+2% +$29.1K 0.05% 298
2016
Q4 		$1.83M Buy
15,839
+175
+1% +$19.5K 0.05% 300
2016
Q3 		$1.64M Sell
15,664
-450
-3% -$48.7K 0.04% 313
2016
Q2 		$1.59M Buy
16,114
+340
+2% +$35.2K 0.04% 312
2016
Q1 		$1.58M Buy
15,774
+600
+4% +$61.8K 0.04% 320
2015
Q4 		$1.82M Hold
15,174
– – 0.04% 298
2015
Q3 		$1.64M Sell
15,174
-100
-0.7% -$12.4K 0.04% 314
2015
Q2 		$1.77M Hold
15,274
– – 0.04% 317
2015
Q1 		$1.76M Sell
15,274
-1,340
-8% -$160K 0.04% 308
2014
Q4 		$1.86M Hold
16,614
– – 0.04% 308
2014
Q3 		$1.57M Buy
16,614
+1,400
+9% +$126K 0.04% 319
2014
Q2 		$1.31M Sell
15,214
-274
-2% -$20.8K 0.03% 289
2014
Q1 		$1.08M Sell
15,488
-230
-1% -$18.2K 0.03% 321
2013
Q4 		$1.33M Sell
15,718
-2,200
-12% -$174K 0.03% 305
2013
Q3 		$1.38M Buy
17,918
+5,856
+49% +$410K 0.03% 302
2013
Q2 		$706K Buy
+12,062
New +$726K 0.02% 342

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Segall Bryant & Hamill's CELG Position: Q4 2019 in Review

Segall Bryant & Hamill sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 18,602 shares — an estimated $1.85M sold.

Segall Bryant & Hamill first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $4.86M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Segall Bryant & Hamill reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Segall Bryant & Hamill sold 18,602 Celgene Corp shares in Q4 2019, an estimated $1.85M.
  • Segall Bryant & Hamill first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Segall Bryant & Hamill's Celgene Corp position peaked at $4.86M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Segall Bryant & Hamill's 13F filing for Q4 2019, filed 11 Feb 2020.